Immunomic Therapeutics, Inc. of ROCKVILLE, MD, a company, filed a Form D amendment with the SEC on 2014-10-15. The offering totals $8.8M, of which $6.8M was reported sold. Industry: Biotechnology.
Showing 25 of 44 people.
| Name | Role | Location |
|---|---|---|
| William G Hearl | Director | Lancaster, PA |
| Bruce F Mackler | Director | Ontario, A6 |
| Ronald D Thiboutot | Director | Harrisburg, PA |
| James D Wishart | Director | Lexington Park, MD |
| William G Hearl | Executive Officer | Lancaster, PA |
| Teri Jones Heiland | Executive Officer | Lancaster, PA |
| Bruce F Mackler | Executive Officer | Ontario, A6 |
| James D Wishart | Executive Officer | Lexington Park, MD |
| William G Hearl | Promoter | Lancaster, PA |
| Yang Gon Jin | Director | ROCKVILLE, MD |
| Steve Park | Director | ROCKVILLE, MD |
| Robert Ahlgren | Director | ROCKVILLE, MD |
| Dong-Gun Kim | Director | ROCKVILLE, MD |
| Dong-Gun Kim | Executive Officer | ROCKVILLE, MD |
| James Wishart | Director | ROCKVILLE, MD |
| Ki-Hong Ahn | Director | ROCKVILLE, MD |
| Matthew Chang | Director | ROCKVILLE, MD |
| James ERIC Wishart | Director | ROCKVILLE, MD |
| C. ERIC WINZER | Director | ROCKVILLE, MD |
| C. ERIC WINZER | Executive Officer | ROCKVILLE, MD |
| Robert ERIC Ahlgren | Director | ROCKVILLE, MD |
| Steve ERIC Park | Director | ROCKVILLE, MD |
| Ki-Hong ERIC Ahn | Director | ROCKVILLE, MD |
| Matthew ERIC Chang | Director | ROCKVILLE, MD |
| Michael ERIC Lack | Director | ROCKVILLE, MD |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-06-02 | D | $16.0M | $6.5M |
| 2024-04-10 | D | $20.9M | $3.0M |
| 2021-01-14 | D/A | $77.7M | $77.7M |
| 2020-02-26 | D | $60.0M | $10.0M |
| 2018-08-03 | D | $315K | $315K |
| 2017-03-15 | D | $10.0M | $4.6M |
| 2014-10-15 | D/A | $8.8M | $6.8M |
| 2014-04-24 | D | $8.8M | $1.0M |
| 2013-06-12 | D | $3.0M | $2.7M |
| 2013-06-12 | D | $1.3M | $1.1M |
| 2013-06-12 | D/A | $2.0M | $1.6M |
| 2012-03-05 | D | $2.0M | $1.1M |